COVID-19-associated severe immune thrombocytopenia

The novel coronavirus disease (COVID-19) is not only a disease that affects the respiratory system but also a systemic disease resulting in various symptoms and complications. Haematological changes are common in patients with COVID-19 but reports of severe immune thrombocytopenia (IT) in patients with COVID-19 are rare. Hereby a case is presented of a 72-year-old male patient who developed severe, symptomatic IT a month after COVID-19. Thereinafter, aetiology, pathophysiology, diagnosis as well as treatment options were widely discussed